AI tool successfully predicts outcomes of immunotherapy in lung cancer

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine. The study reported findings from the I3LUNG project, a large international trial aimed at improving the treatment of metastatic NSCLC by developing AI-based predictive models that can help determine the best therapeutic approach for each individual.

≈